We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Smart Sutures Could Help Patients Heal After Surgery

By HospiMedica International staff writers
Posted on 18 May 2023
Print article
Image: Tissue-derived “smart” sutures can only hold tissue in place, as well as detect inflammation and release drugs (Photo courtesy of MIT)
Image: Tissue-derived “smart” sutures can only hold tissue in place, as well as detect inflammation and release drugs (Photo courtesy of MIT)

Originating from the times of ancient Rome, catgut sutures — created from the purified collagen of bovines, ovines, or caprines, but not felines — are noted for their strength and their capacity to naturally disintegrate within roughly three months. Despite the availability of synthetic absorbable sutures, catgut sutures remain in use across various surgical procedures. Now, engineers have created "smart" sutures, drawing inspiration from age-old sutures. These not only secure tissue but also sense inflammation and deliver drugs. These new sutures, based on animal tissue, are similar to the catgut sutures. However, in a modern adaptation, engineers have coated these sutures with hydrogels capable of being embedded with sensors, medication, or cells that release therapeutic molecules. Researchers anticipate that these sutures can assist patients with Crohn's disease in their recovery after intestinal surgery. Furthermore, the researchers suggest these sutures could also be modified for healing wounds or surgical cuts elsewhere in the body.

A team of engineers at Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) set out to improve upon the pre-existing tissue-derived suture by creating a material that was not only tough and absorbable but also exhibited enhanced functionalities like sensing and drug delivery. These sutures could be of particular benefit for Crohn's disease patients requiring partial intestinal removal due to obstructions caused by severe scarring or inflammation. The operation involves rejoining the remaining ends of the intestine after a section has been removed. However, if the seal isn't secure, dangerous leaks could develop for the patient. Aiming to mitigate this risk, the MIT team sought to design a suture that could not only hold the tissue together but also detect inflammation — a potential indication of insufficient healing in the resealed intestines.

The researchers crafted their new sutures from pig tissue, which they "decellularized" with detergents to lower the likelihood of inflammation in the host tissue. This method resulted in a cell-free material known as "De-gut", comprising structural proteins like collagen and other biomolecules found in the extracellular matrix surrounding cells. After drying and twisting the tissue into strands, the team assessed its tensile strength, a measure of how much stretching the tissue can endure before breaking, and found it comparable to commercially available catgut sutures. It was also observed that the De-gut sutures induced much less immune response from the surrounding tissue compared to traditional catgut. The team then aimed to enhance the suture material with additional capabilities by coating the sutures with a layer of hydrogel, enabling the integration of various types of cargo — microparticles capable of sensing inflammation, different drug molecules, or living cells.

For the sensor application, the team engineered microparticles coated with peptides that are released when inflammation-linked enzymes known as MMPs are present in the tissue. These peptides can be detected using a simple urine test. The researchers also demonstrated that the hydrogel coating could transport drugs used for treating inflammatory bowel disease, including a steroid called dexamethasone and a monoclonal antibody known as adalimumab. These drugs were delivered via microparticles created from FDA-approved polymers such as PLGA and PLA, which help control the rate of drug release. The researchers suggest that this method could be tailored to deliver other types of drugs, like antibiotics or chemotherapy drugs.

Additionally, these smart sutures could be utilized to deliver therapeutic cells, such as stem cells. To investigate this, the researchers incorporated stem cells, engineered to express a fluorescent marker, into the sutures, finding that these cells remained viable for at least seven days when implanted in mice. These cells were also capable of producing vascular endothelial growth factor (VEGF), a growth factor that stimulates blood cell growth. The researchers are now focusing on further testing of these potential applications, as well as scaling up the production process for these sutures. They also plan to investigate the potential of using these sutures in body regions beyond the gastrointestinal tract.

“What we have is a suture that is bioderived and modified with a hydrogel coating capable of being a reservoir for sensors for inflammation, or for drugs such as monoclonal antibodies to treat inflammation,” said Giovanni Traverso, an associate professor of mechanical engineering at MIT, a gastroenterologist at Brigham and Women’s Hospital, and the senior author of the study. “Remarkably, the coating also has the capacity to retain cells that are viable for a prolonged period.”

Related Links:
MIT

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Supplier
IMRT Thorax Phantom
CIRS Model 002LFC
New
Surgical Headlight
PLT-60F LED
New
Non-Vented Full Face NIV Mask
F&P Visairo RT075

Print article
Radcal

Channels

Critical Care

view channel
Image: The new blood test could prevent some of the 350,000 sepsis deaths in the U.S. annually (Photo courtesy of Cytovale)

Sepsis Test Could Save Lives in Emergency Departments, Study Suggests

Sepsis poses a severe, life-endangering illness that arises when an infection triggers a body-wide chain reaction, potentially causing multiple organs to fail quickly. Prompt and accurate diagnosis is... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more

Business

view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.